It looks like your browser is not up to date.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

Kanabo Group plc (KNB) ORD GBP0.025

Sell:19.00p Buy:20.00p 0 Change: 0.50p (2.63%)
Market closed Prices as at close on 18 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:19.00p
Buy:20.00p
Change: 0.50p (2.63%)
Market closed Prices as at close on 18 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
Sell:19.00p
Buy:20.00p
Change: 0.50p (2.63%)
Market closed Prices as at close on 18 June 2021 Prices delayed by at least 15 minutes | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

Kanabo Group PLC, formerly Spinnaker Opportunities Plc, is a United Kingdom-based medical cannabis company. The Company is principally focused on distribution of cannabis-derived products for medical patients, and non- tetrahydrocannabinol (THC) products for Cannabidiol (CBD) consumers. It has developed a formula for sleep disorders (insomnia), three CBD formulations for Reload, Relax, and Repair, and the VapePod vaporization delivery device. The Company's R&D lab is set up in the Weizmann Science Park. The Company's clinical and validation activities, including safety and efficiency tests, are conducted in Israel. The Company is selling its initial products in Europe. It is also engaged in conducting research and development (R&D) to develop cannabis oil formulas, medical-grade vaporizers, and various non-smoking consumption solutions.

Contact details

Address:
59-60 Russell Square
LONDON
WC1B 4HP
United Kingdom
Telephone:
+ (0)
Website:
www.spinnakeropportunities.uk/

Important dates

Future events
AGM 28 June 2021 28/06/21
Past events
Final results 02 June 2021 02/06/21
Annual report 02 June 2021 02/06/21
General meeting 15 February 2021 15/02/21

General stock information

EPIC:
KNB
ISIN:
GB00BYQCS703
Market cap:
£71.84 million
Shares in issue:
368.41 million
Sector:
Nonequity Investment Instruments
Exchange:
London Stock Exchange
Currency:
Sterling pence
Indices:
n/a

Key personnel

  • Avihu Tamir
    Chief Executive Officer, Executive Director
  • Howard Rubenstein
    Company Secretary

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by NBTrader.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.